Transgender women (TW) in Central America are the population most-affected by HIV/AIDS in the region. Antiretroviral therapy (ART) coverage and adherence among TW is assumed lower than national estimates because TW face additional barriers to care, greater stigma, and limited family and emotional support.
To inform a USAID-funded Combination Prevention Program in Central America, PASMO conducted a qualitative study to explore the barriers to adherence faced by people living with HIV, including TW. This study examines a subset of 10 life history interviews and two focus groups conducted with HIV-positive TW in Nicaragua, El Salvador, and Costa Rica.
The results were presented at the 10th International Conference on HIV Treatment and Prevention Adherence.
- Populations Served
- Transgender Women
- Health Areas
- HIV and Sexually Transmitted Infections
- Resource Types
- Data, Presentations, Qualitative
- Costa Rica, El Salvador, Nicaragua
- Antiretroviral Treatment (ART), Screening, Diagnosis, and Treatment
- USAID Combination Prevention Program for HIV in Central America
PSI Data Use and Authorship
Anyone interested in analyzing our data, publishing their findings in written works, or presenting them at a conference is required to submit a Data Use & Authorship Proposal. In the proposal, users agree to abide by a pledge of confidentiality, stipulations for data use and authorship guidelines. More on our data use and authorship policies.